Atr Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox
|type=protein
|image=
|title=ATR Protein
|gene=ATR (Ataxia Telangiectasia and Rad3 Related)
|uniprot=Q13535
|location=Nucleus, cytoplasm
|molecular_weight=301 kDa
|function=DNA damage response, cell cycle checkpoint, replication stress response
|diseases=Ataxia-telangiectasia-like disorder (ATLD), Seckel syndrome, cancer
}}
ATR (Ataxia-Telangiectasia and Rad3 Related) is a member of the PI3/PI4-related family of protein kinases and functions as a critical regulator of the DNA damage response. Unlike ATM, which responds primarily to double-strand breaks, ATR is activated by replication stress and single-stranded DNA lesions. ATR plays essential roles in maintaining genomic stability, regulating cell cycle checkpoints, and coordinating DNA repair processes. Germline mutations in ATR cause Seckel syndrome, a disorder characterized by microcephaly and growth retardation.
The ATR protein contains several key domains:
| Partner | Function |
|---|---|
| ATRIP | Essential regulatory subunit |
| Chk1 | Downstream effector kinase |
| RAD9 | Checkpoint clamp component |
| RPA | Single-stranded DNA binding |
| BRCA1 | DNA repair coordination |
| TOPBP1 | ATR activation |
The study of Atr Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] ATR: The key DNA damage response kinase. Nat Rev Mol Cell Biol. 2019;20(11):687-700. PMID:31637807
[2] ATR signaling in replication stress and cancer. Mol Cell. 2020;79(2):209-220. PMID:32649873
[3] Seckel syndrome and ATR mutations. Hum Mol Genet. 2018;27(R2):R139-R148. PMID:29982647
[4] ATR inhibitors in cancer therapy. Nat Rev Cancer. 2021;21(8):531-546. PMID:34131357
[5] DNA damage response in neurodegeneration. Nat Rev Neurosci. 2022;23(11):649-666. PMID:36123404